Exome Asset Management LLC — 13F Holdings & Portfolio
CIK 2011932 · latest 13F-HR filed 2026-05-15
Exome Asset Management LLC manages $193.3M in 13F-reported U.S. long-equity assets across 56 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are PRAX (7.58%), COGT (5.54%), ELVN (4.46%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 14 new positions, exited 22, added to 9, and trimmed 20.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$193.3M
Long-equity book
56
Distinct positions
2026-03-31
Filed 2026-05-15
+14 / −22 / ↑9 / ↓20
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ENLIVEN THERAPEUTICS INC$5.2M +152.0%
- ALUMIS INC$3.3M +115.6%
- UNITEDHEALTH GROUP INC$1.6M +80.7%
- CORBUS PHARMACEUTICALS HLDGS$1.1M +93.6%
- ADAGENE INC$884.6K +44.1%
Top Trims
- PRAXIS PRECISION MEDICINES I-$2.5M -14.5%
- GUARDANT HEALTH INC-$2.4M -23.8%
- ELI LILLY & CO-$2.0M -23.6%
- ELEVANCE HEALTH INC FORMERLY-$1.7M -28.7%
- VERA THERAPEUTICS INC-$1.7M -26.6%
New Positions
- INSMED INC$4.4M
- MOONLAKE IMMUNOTHERAPEUTICS$4.0M
- RHYTHM PHARMACEUTICALS INC$3.5M
- BOSTON SCIENTIFIC CORP$3.0M
- ALKERMES PLC$3.0M
Exited Positions
- WAVE LIFE SCIENCES LTD$7.2M
- ASTRAZENECA PLC$5.3M
- JAZZ PHARMACEUTICALS PLC$4.5M
- IMMUNOVANT INC$4.0M
- UNIVERSAL HLTH SVCS INC$3.8M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $14.6M | 7.58% | 45,469 | SH |
| 2 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $10.7M | 5.54% | 278,533 | SH |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $8.6M | 4.46% | 220,091 | SH |
| 4 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $8.3M | 4.27% | 110,064 | SH |
| 5 | SPDR SERIES TRUST Put | XBI | 78464A870 | $7.7M | 3.96% | 60,000 | SH |
| 6 | GUARDANT HEALTH INC | GH | 40131M109 | $7.6M | 3.95% | 82,736 | SH |
| 7 | CYTOKINETICS INC | CYTK | 23282W605 | $6.8M | 3.54% | 103,718 | SH |
| 8 | ELI LILLY & CO | LLY | 532457108 | $6.4M | 3.34% | 7,012 | SH |
| 9 | ALUMIS INC | ALMS | 022307102 | $6.2M | 3.18% | 279,176 | SH |
| 10 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $5.0M | 2.59% | 67,492 | SH |
| 11 | VERA THERAPEUTICS INC | VERA | 92337R101 | $4.6M | 2.39% | 114,991 | SH |
| 12 | INSMED INC | INSM | 457669307 | $4.4M | 2.25% | 26,651 | SH |
| 13 | ELEVANCE HEALTH INC FORMERLY | ELV | 036752103 | $4.3M | 2.22% | 14,677 | SH |
| 14 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $4.2M | 2.19% | 125,060 | SH |
| 15 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $4.2M | 2.16% | 7,053 | SH |
| 16 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 61559X104 | $4.0M | 2.08% | 215,376 | SH |
| 17 | CYTOKINETICS INC Put | CYTK | 23282W955 | $4.0M | 2.05% | 60,000 | SH |
| 18 | NATERA INC | NTRA | 632307104 | $3.7M | 1.93% | 18,650 | SH |
| 19 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $3.5M | 1.83% | 40,581 | SH |
| 20 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $3.5M | 1.80% | 12,862 | SH |
| 21 | APELLIS PHARMACEUTICALS INC | APLS | 03753U106 | $3.4M | 1.78% | 85,517 | SH |
| 22 | VERASTEM INC | VSTM | 92337C203 | $3.4M | 1.75% | 636,700 | SH |
| 23 | 10X GENOMICS INC | TXG | 88025U109 | $3.3M | 1.69% | 154,194 | SH |
| 24 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $3.0M | 1.57% | 48,347 | SH |
| 25 | ALKERMES PLC | ALKS | G01767105 | $3.0M | 1.54% | 84,103 | SH |
| 26 | BEONE MEDICINES LTD Call | BEIGF | 07725L902 | $3.0M | 1.54% | 10,000 | SH |
| 27 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $3.0M | 1.53% | 179,484 | SH |
| 28 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $2.9M | 1.52% | 6,358 | SH |
| 29 | ADAGENE INC | ADAG | 005329107 | $2.9M | 1.49% | 736,845 | SH |
| 30 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $2.9M | 1.48% | 45,721 | SH |
| 31 | CRESCENT BIOPHARMA INC. | CBIO | G2545C104 | $2.8M | 1.46% | 153,191 | SH |
| 32 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $2.8M | 1.43% | 278,302 | SH |
| 33 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $2.6M | 1.37% | 88,510 | SH |
| 34 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $2.5M | 1.27% | 521,468 | SH |
| 35 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $2.4M | 1.23% | 159,341 | SH |
| 36 | ALUMIS INC Put | ALMS | 022307952 | $2.3M | 1.20% | 105,000 | SH |
| 37 | GLAUKOS CORP | GKOS | 377322102 | $2.2M | 1.16% | 20,874 | SH |
| 38 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 21833P301 | $2.2M | 1.14% | 234,136 | SH |
| 39 | PENUMBRA INC | PEN | 70975L107 | $2.1M | 1.07% | 6,300 | SH |
| 40 | SOLENO THERAPEUTICS INC | SLNO | 834203309 | $2.1M | 1.07% | 61,673 | SH |
| 41 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $1.7M | 0.89% | 45,796 | SH |
| 42 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $1.6M | 0.82% | 80,730 | SH |
| 43 | LIQUIDIA CORPORATION Put | LQDA | 53635D952 | $1.5M | 0.78% | 40,000 | SH |
| 44 | NOVABRIDGE BIOSCIENCES | NBP | 44975P103 | $1.4M | 0.73% | 576,960 | SH |
| 45 | CENTESSA PHARMACEUTICALS PLC Put | CNTA | 152309950 | $1.4M | 0.71% | 34,700 | SH |
| 46 | IDEAYA BIOSCIENCES INC Call | IDYA | 45166A902 | $1.3M | 0.69% | 40,000 | SH |
| 47 | IDEAYA BIOSCIENCES INC Put | IDYA | 45166A902 | $1.3M | 0.69% | 40,000 | SH |
| 48 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 35104E100 | $1.2M | 0.63% | 130,564 | SH |
| 49 | NEXTCURE INC | NXTC | 65343E207 | $1.2M | 0.63% | 115,500 | SH |
| 50 | PALISADE BIO INC | PALI | 696389402 | $1.1M | 0.54% | 600,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $193.3M | 56 | 0001420506-26-001033 |
| 2025-12-31 | 2026-02-13 | $209.1M | 60 | 0001420506-26-000376 |
| 2025-09-30 | 2025-11-14 | $165.1M | 68 | 0001420506-25-003369 |